This September marked the 20th anniversary of ICM+, a groundbreaking clinical research software developed by Dr Peter Smielewski and Professor Marek Czosnyka. Over the past two decades, ICM+ has advanced neurological intensive care by providing real-time multimodality monitoring, analysis, and data storage.
Hear from the key figures who have been instrumental in the journey of ICM+ and learn about its impact on clinical practices and patient outcomes worldwide:
- Dr Peter Smielewski, Head of Brain Physics Laboratory, University of Cambridge
- Dr Marek Czosnyka, Professor Emeritus of Brain Physics, University of Cambridge
- Professor David Menon, Professor of Anaesthesia, University of Cambridge
- Professor Peter Hutchinson, Professor of Neurosurgery, University of Cambridge
- Sarah Murgraff, Commercialisation Associate, Cambridge Enterprise
Changing the landscape of clinical technology
ICM+ stands out as a pioneering clinical research software solution, offering high-resolution data collection and real-time analysis from multiple bedside monitoring sources. This innovative tool facilitates the collation, integration, user-configurable analysis, and presentation of high-resolution, fluctuating data generated in neurological intensive care environments.
Licensed to hospitals worldwide, ICM+ implements methodologies introduced by the Brain Physics group at the Department of Clinical Neurosciences, University of Cambridge, UK, with over 500 publications on PubMed. Research licenses have been granted to over 200 institutions across 40 countries, resulting in nearly 800 agreements globally.
The software is available for licensing from Cambridge Enterprise.
Find out more
Tags: ICM+, Intensive Care, Neuromonitoring, research tools